FitLife Brands Announces its Participation at the 37th Annual Roth Conference and Provides Financial and Operational Update
FitLife Brands (FTLF), a nutritional supplements and wellness products provider, has announced its participation in the 37th Annual Roth Conference on March 17-18, 2025. The company provided a financial update ahead of the conference, revealing strong performance metrics for 2024:
- Anticipated net revenue of $64-65 million, up 21-23% from 2023
- Expected Adjusted EBITDA of $14.0-14.2 million, increasing 38-40% year-over-year
- Projected net income of $8.9-9.1 million, growing 68-72% compared to 2023
As of December 31, 2024, FitLife reported $4.5 million in cash, $13.1 million outstanding on its term loan, and no balance on its revolver. The company's shares outstanding totaled 9,218,528 as of March 12, 2025.
FitLife Brands (FTLF), un fornitore di integratori nutrizionali e prodotti per il benessere, ha annunciato la sua partecipazione alla 37ª Conferenza Annuale Roth che si terrà il 17-18 marzo 2025. L'azienda ha fornito un aggiornamento finanziario in vista della conferenza, rivelando solidi indicatori di performance per il 2024:
- Ricavi netti previsti di $64-65 milioni, in aumento del 21-23% rispetto al 2023
- EBITDA rettificato atteso di $14.0-14.2 milioni, in crescita del 38-40% anno su anno
- Utile netto previsto di $8.9-9.1 milioni, in aumento del 68-72% rispetto al 2023
Al 31 dicembre 2024, FitLife ha riportato $4.5 milioni in contante, $13.1 milioni di prestito a termine in sospeso e nessun saldo sul suo prestito rotativo. Le azioni in circolazione dell'azienda ammontavano a 9.218.528 al 12 marzo 2025.
FitLife Brands (FTLF), un proveedor de suplementos nutricionales y productos de bienestar, ha anunciado su participación en la 37ª Conferencia Anual Roth que se llevará a cabo del 17 al 18 de marzo de 2025. La empresa proporcionó una actualización financiera antes de la conferencia, revelando sólidos indicadores de rendimiento para 2024:
- Ingresos netos anticipados de $64-65 millones, un aumento del 21-23% en comparación con 2023
- EBITDA ajustado esperado de $14.0-14.2 millones, aumentando un 38-40% interanual
- Ingreso neto proyectado de $8.9-9.1 millones, creciendo un 68-72% en comparación con 2023
Al 31 de diciembre de 2024, FitLife reportó $4.5 millones en efectivo, $13.1 millones pendientes en su préstamo a plazo y ningún saldo en su línea de crédito. Las acciones en circulación de la empresa totalizaban 9,218,528 al 12 de marzo de 2025.
FitLife Brands (FTLF), 영양 보충제 및 웰니스 제품 제공업체,는 2025년 3월 17일부터 18일까지 열리는 제37회 연례 로스 회의에 참여한다고 발표했습니다. 회사는 회의에 앞서 2024년 강력한 성과 지표를 공개하며 재무 업데이트를 제공했습니다:
- 예상 순수익 $64-65 백만, 2023년 대비 21-23% 증가
- 예상 조정 EBITDA $14.0-14.2 백만, 전년 대비 38-40% 증가
- 예상 순이익 $8.9-9.1 백만, 2023년 대비 68-72% 증가
2024년 12월 31일 기준으로 FitLife는 $4.5 백만의 현금, $13.1 백만의 장기 대출 잔액 및 회전 신용 대출에 잔액이 없음을 보고했습니다. 2025년 3월 12일 기준으로 회사의 발행 주식 총수는 9,218,528주였습니다.
FitLife Brands (FTLF), un fournisseur de suppléments nutritionnels et de produits de bien-être, a annoncé sa participation à la 37ème Conférence Annuelle Roth qui se déroulera les 17 et 18 mars 2025. L'entreprise a fourni une mise à jour financière avant la conférence, révélant de solides indicateurs de performance pour 2024 :
- Chiffre d'affaires net anticipé de $64-65 millions, en hausse de 21-23% par rapport à 2023
- EBITDA ajusté attendu de $14.0-14.2 millions, en augmentation de 38-40% d'une année sur l'autre
- Bénéfice net projeté de $8.9-9.1 millions, en croissance de 68-72% par rapport à 2023
Au 31 décembre 2024, FitLife a déclaré avoir $4.5 millions en liquidités, $13.1 millions dus sur son prêt à terme, et aucun solde sur sa ligne de crédit renouvelable. Le nombre d'actions en circulation de l'entreprise s'élevait à 9 218 528 au 12 mars 2025.
FitLife Brands (FTLF), ein Anbieter von Nahrungsergänzungsmitteln und Wellnessprodukten, hat seine Teilnahme an der 37. jährlichen Roth-Konferenz am 17. und 18. März 2025 bekannt gegeben. Das Unternehmen hat vor der Konferenz ein finanzielles Update bereitgestellt und starke Leistungskennzahlen für 2024 enthüllt:
- Erwarteter Nettoumsatz von $64-65 Millionen, ein Anstieg von 21-23% im Vergleich zu 2023
- Erwartetes bereinigtes EBITDA von $14.0-14.2 Millionen, ein Anstieg von 38-40% im Jahresvergleich
- Prognostizierter Nettogewinn von $8.9-9.1 Millionen, ein Wachstum von 68-72% im Vergleich zu 2023
Zum 31. Dezember 2024 berichtete FitLife über $4.5 Millionen in bar, $13.1 Millionen ausstehenden auf seinem Terminkredit und keinen Saldo auf seiner revolvierenden Kreditlinie. Die ausstehenden Aktien des Unternehmens beliefen sich am 12. März 2025 auf insgesamt 9.218.528.
- Net revenue growth of 21-23% year-over-year
- Significant net income increase of 68-72%
- Strong EBITDA growth of 38-40%
- No outstanding balance on revolver facility
- Healthy cash position of $4.5 million
- Substantial term loan debt of $13.1 million outstanding
Omaha, NE, March 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the 37th Annual Roth Conference on Monday and Tuesday, March 17-18, 2025. Investors who are interested in meeting with FitLife management should submit their requests through their Roth representative.
In conjunction with its participation in the conference, the Company has prepared an updated investor presentation which will be filed with the Securities and Exchange Commission on Form 8-K in advance of the conference.
The Company plans to report its financial performance for the fourth quarter and full year of 2024 with the Securities and Exchange Commission on Form 10-K on March 27, 2025. However, in order to facilitate upcoming investor discussions, the Company is providing the following financial and operational update regarding the Company’s recent performance:
- Net revenue for the full year 2024 is anticipated to be between
$64 -65 million, an increase of 21-23% compared to 2023. - Adjusted EBITDA for the full year 2024 is anticipated to be between
$14.0 -14.2 million, an increase of 38-40% compared to 2023. - Net income for the full year 2024 is anticipated to be between
$8.9 -9.1 million, an increase of 68-72% compared to 2023. - As of December 31st, 2024, the Company had
$13.1 million outstanding on its term loan and no balance outstanding on its revolver. - As of December 31st, 2024, the Company had
$4.5 million of cash. - Shares outstanding as of March 12, 2025 were 9,218,528.
About FitLife Brands
FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers. FitLife markets more than 250 different products primarily online, but also through domestic and international GNC® franchise locations as well as through various other retail locations. FitLife is headquartered in Omaha, Nebraska. For more information, please visit our website at www.fitlifebrands.com.
Forward-Looking Statements
Statements in this release that are forward-looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to, the ability of the Company to continue to grow revenue, and the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in the Company's filings with the Securities and Exchange Commission including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.
Non-GAAP Financial Measures
This press release contains certain financial measures defined as “non-GAAP financial measures” by the SEC, including non-GAAP adjusted EBITDA. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
As presented herein, non-GAAP EBITDA excludes interest, foreign exchange gains and losses, income taxes, and depreciation and amortization. Adjusted non-GAAP EBITDA excludes, in addition to interest, foreign exchange gains and losses, taxes, depreciation and amortization, equity-based compensation, M&A/integration activities, and non-recurring gains or losses. The Company believes the non-GAAP measures provide useful information to both management and investors by excluding certain expenses and other items that may not be indicative of its core operating results and business outlook. The Company believes that the inclusion of non-GAAP measures in the financial presentation herein allows investors to compare the Company’s financial results with the Company’s historical financial results and is an important measure of the Company’s comparative financial performance.
investor@fitlifebrands.com
FAQ
What is FitLife Brands' (FTLF) projected revenue growth for 2024?
How much did FitLife Brands' (FTLF) net income grow in 2024?
What is FitLife Brands' (FTLF) cash position as of December 2024?
When will FitLife Brands (FTLF) release its Q4 and full-year 2024 results?
